Literature DB >> 15715757

Why do doctors dislike treating people with somatoform disorder?

Saxby Pridmore1, Paul Skerritt, Jamshid Ahmadi.   

Abstract

OBJECTIVE: To consider the question of why doctors dislike treating people with somatoform disorder, with a view to assisting debate and improving services.
METHODS: The literature was examined, and compared with clinical experience.
RESULTS: Psychological, sociological and evolutionary theory make relevant contributions. Important factors include that these conditions are problematic and positive outcomes may not be possible given current knowledge and clinical skills and techniques. Patients may not accept that their problem is a form of psychiatric or brain disorder. Most importantly, the doctor may not accept that somatoform disorders are beyond the control of patients, setting the scene for irritation and unsatisfactory interactions.
CONCLUSIONS: There are many factors that underlie the dislike of some doctors for treating people with somatoform disorder. There is a pressing need for educational efforts to help students and doctors accept that the symptoms of somatoform disorder are beyond the control of those who suffer them.

Entities:  

Mesh:

Year:  2004        PMID: 15715757     DOI: 10.1080/j.1039-8562.2004.02085.x

Source DB:  PubMed          Journal:  Australas Psychiatry        ISSN: 1039-8562            Impact factor:   1.369


  3 in total

1.  Facial pain: After the dentist and ENT have finished.

Authors:  Ronald Kanner
Journal:  Neurol Clin Pract       Date:  2012-09

2.  High prevalence of depression among Iranian patients with first onset pseudoseizures.

Authors:  Alireza Farnam; Mohammad Ali Goreishizadeh; Sara Farhang; Fatemeh Abdolaliyan
Journal:  Indian J Psychiatry       Date:  2008-10       Impact factor: 1.759

3.  Functional illness in primary care: dysfunction versus disease.

Authors:  Nefyn Williams; Clare Wilkinson; Nigel Stott; David B Menkes
Journal:  BMC Fam Pract       Date:  2008-05-15       Impact factor: 2.497

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.